- Home
- CAC vs AUTL Comparison
CAC vs AUTL Comparison
Compare CAC & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAC
- AUTL
- Stock Information
- Founded
- CAC 1875
- AUTL 2014
- Country
- CAC United States
- AUTL United Kingdom
- Employees
- CAC N/A
- AUTL N/A
- Industry
- CAC Major Banks
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CAC Finance
- AUTL Health Care
- Exchange
- CAC Nasdaq
- AUTL Nasdaq
- Market Cap
- CAC N/A
- AUTL 625.4M
- IPO Year
- CAC 1997
- AUTL 2018
- Fundamental
- Price
- CAC $43.10
- AUTL $2.47
- Analyst Decision
- CAC Hold
- AUTL Strong Buy
- Analyst Count
- CAC 3
- AUTL 5
- Target Price
- CAC $47.33
- AUTL $9.32
- AVG Volume (30 Days)
- CAC 62.5K
- AUTL 1.8M
- Earning Date
- CAC 07-29-2025
- AUTL 08-07-2025
- Dividend Yield
- CAC 3.91%
- AUTL N/A
- EPS Growth
- CAC 2.54
- AUTL N/A
- EPS
- CAC 3.09
- AUTL N/A
- Revenue
- CAC $184,324,000.00
- AUTL $9,011,000.00
- Revenue This Year
- CAC $40.83
- AUTL $461.76
- Revenue Next Year
- CAC $5.29
- AUTL $112.66
- P/E Ratio
- CAC $13.92
- AUTL N/A
- Revenue Growth
- CAC 13.26
- AUTL N/A
- 52 Week Low
- CAC $33.83
- AUTL $1.11
- 52 Week High
- CAC $50.07
- AUTL $5.00
- Technical
- Relative Strength Index (RSI)
- CAC 70.29
- AUTL 69.22
- Support Level
- CAC $42.85
- AUTL $2.24
- Resistance Level
- CAC $43.78
- AUTL $2.53
- Average True Range (ATR)
- CAC 0.98
- AUTL 0.13
- MACD
- CAC 0.37
- AUTL -0.00
- Stochastic Oscillator
- CAC 95.06
- AUTL 88.55
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.